Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Legal Names
Legal name
Similar Companies1000
Cend Therapeutics Inc.
Cend Therapeutics Inc. develops cancer therapies that overcome drug delivery barriers to solid tumors.
Sector
Subsector
Keywords
Location
total rounds
total raised
Belharra Therapeutics
Belharra Therapeutics is a drug discovery company specializing in transformative medicines.
Sector
Subsector
Location
total rounds
total raised
Sareum Holdings PLC
Sareum develops targeted therapeutics for cancer and autoimmune diseases, aiming to license them to pharmaceutical companies.
Sector
Subsector
Location
total rounds
total raised
NovelMed Therapeutics
NovelMed Therapeutics develops transformative treatments for orphan and non-orphan diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds9
Number of Funding Rounds
Money Raised
Their latest funding was raised on 02.07.2024. Their latest investor Michael J. Fox Foundation. Their latest round Grant
Michael J. Fox Foundation
Michael J. Fox Foundation is a non-profit research firm dedicated to finding better treatments and a cure for Parkinson's disease.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
IP Group
IP Group creates value for shareholders and partners by commercialising intellectual property from research institutions.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
Sofinnova Partners
Sofinnova Partners is a venture capital firm that invests in life sciences.
Sector
Subsector
Location
total rounds
count Of Investments
count Of Exists
Rosetta Capital
Rosetta Capital Limited is a London-based private equity and venture capital firm focused on direct secondary investments.
Sector
Subsector
Keywords
Location
count Of Investments
Pfizer Venture Investments
Pfizer Venture Investments is a VC firm.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Michael J. Fox Foundation
Michael J. Fox Foundation is a non-profit research firm dedicated to finding better treatments and a cure for Parkinson's disease.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors10
Number of lead investors
Number of investors
Michael J. Fox Foundation
Michael J. Fox Foundation is a non-profit research firm dedicated to finding better treatments and a cure for Parkinson's disease.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
IP Group
IP Group creates value for shareholders and partners by commercialising intellectual property from research institutions.
Sector
Subsector
Location
total rounds
total raised
count Of Investments
count Of Exists
Roche Venture Fund
Roche Venture Fund invests in and developing innovative life science companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders3
Xavier Jacq
XavierXavier Jacq obtained his PhD from Louis Pasteur University in Strasbourg, France in 1997. He then carried out post-doctoral training at Columbia University, NY, USA in cancer biology. Following a first industry experience at Sanofi-Synthelabo, Xavier joined Hybrigenics in Paris as a project leader in 2002 where he became interested in targeting the ubiquitin proteasome pathway in the oncology field. He is an inventor on multiple patents related to inhibitors of deubiquitylating enzymes and assays.
organization founded
Xavier Jacq
Steve Jackson
After graduating in biochemistry from the University of Leeds followed by a PhD from Edinburgh University, Steve carried out post-doctoral training in the lab of Professor Robert Tjian at Berkeley, USA. In 1991, he became a group leader at what is now the Gurdon Institute in Cambridge, UK, where he is now Senior Group Leader and Head of Cancer Research UK Laboratories. Steve is also the University of Cambridge’s Frederick James Quick Chair of Biology. His research has been instrumental in shaping our understanding of cellular responses to DNA damage and of how defects in these responses contribute to disease. Steve co-founded KuDOS Pharma which was acquired by AstraZeneca in 2006. Olaparib, which was originated by KuDOS, was approved for advanced BRCA+ ovarian cancer in USA and Europe in 2014.
current job
organization founded
Steve Jackson
Niall Martin
Niall Martin is the Chief Executive Officer at Artios Pharma.
current job
organization founded
Niall Martin
Employee Profiles11
Michael Koslowski
Executive Vice President, Research and Development and Chief Medical Officer
Activity
Recent News2
The graph reveals the ratio (%) of positive news articles in a chosen time range